Stay Granted In Lipitor Case Pending Del. Decision
Pfizer Inc. has won a stay of litigation in a patent dispute over the blockbuster cholesterol drug Lipitor, a move the court says will avoid unnecessarily duplicative litigation against generics maker...To view the full article, register now.
Already a subscriber? Click here to view full article